Literature DB >> 20497954

The pathogenicity of self-antigen decreases at high levels of autoantigenicity: a computational approach.

Anmar Khadra1, Pere Santamaria, Leah Edelstein-Keshet.   

Abstract

Recent experimental evidence suggests that antigenic stability facilitates antigen shuttling from target tissue to dendritic cells (DCs), enabling cross-priming of naive T cells. On the other hand, antigenic stability affects the efficiency of peptide-MHC (p-MHC) complex formation, altering a target cell's susceptibility to killing by the resulting CTLs. Using a mathematical model, we show how antigenic stability and p-MHC production efficiency interplay in autoantigenicity and pathogenic potential of target cell proteins in autoimmune disease. We consider protein allocated to both rapidly degraded versus stable functional pools [fractions f, 1 - f], contributing, with relative efficiency eta, to p-MHC presentation on a target cell, as well as to cross-presentation on a DC; we analyze the combined effect of these parameters. Our results suggest that autoantigenicity and pathogenicity (ability to elicit T cell activation versus target cell lysis) are not equivalent and that pathogenicity peaks at low to moderate levels of autoantigenicity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20497954      PMCID: PMC2892361          DOI: 10.1093/intimm/dxq041

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  43 in total

1.  Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library.

Authors:  F S Wong; J Karttunen; C Dumont; L Wen; I Visintin; I M Pilip; N Shastri; E G Pamer; C A Janeway
Journal:  Nat Med       Date:  1999-09       Impact factor: 53.440

Review 2.  Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules?

Authors:  J W Yewdell; L C Antón; J R Bennink
Journal:  J Immunol       Date:  1996-09-01       Impact factor: 5.422

3.  Acceleration of spontaneous diabetes in TCR-beta-transgenic nonobese diabetic mice by beta-cell cytotoxic CD8+ T cells expressing identical endogenous TCR-alpha chains.

Authors:  J Verdaguer; J W Yoon; B Anderson; N Averill; T Utsugi; B J Park; P Santamaria
Journal:  J Immunol       Date:  1996-11-15       Impact factor: 5.422

4.  Prevalent CD8(+) T cell response against one peptide/MHC complex in autoimmune diabetes.

Authors:  B Anderson; B J Park; J Verdaguer; A Amrani; P Santamaria
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

5.  Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs.

Authors:  M L Albert; B Sauter; N Bhardwaj
Journal:  Nature       Date:  1998-03-05       Impact factor: 49.962

6.  Beta cell apoptosis in T cell-mediated autoimmune diabetes.

Authors:  M O Kurrer; S V Pakala; H L Hanson; J D Katz
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

7.  Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor alpha chain gene rearrangement.

Authors:  T P DiLorenzo; R T Graser; T Ono; G J Christianson; H D Chapman; D C Roopenian; S G Nathenson; D V Serreze
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

8.  Beta-cell-cytotoxic CD8+ T cells from nonobese diabetic mice use highly homologous T cell receptor alpha-chain CDR3 sequences.

Authors:  P Santamaria; T Utsugi; B J Park; N Averill; S Kawazu; J W Yoon
Journal:  J Immunol       Date:  1995-03-01       Impact factor: 5.422

9.  Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes.

Authors:  P Höglund; J Mintern; C Waltzinger; W Heath; C Benoist; D Mathis
Journal:  J Exp Med       Date:  1999-01-18       Impact factor: 14.307

10.  Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice.

Authors:  J Verdaguer; D Schmidt; A Amrani; B Anderson; N Averill; P Santamaria
Journal:  J Exp Med       Date:  1997-11-17       Impact factor: 14.307

View more
  7 in total

1.  Continuum model of T-cell avidity: Understanding autoreactive and regulatory T-cell responses in type 1 diabetes.

Authors:  Majid Jaberi-Douraki; Massimo Pietropaolo; Anmar Khadra
Journal:  J Theor Biol       Date:  2015-08-10       Impact factor: 2.691

2.  Quantifying immunoregulation by autoantigen-specific T-regulatory type 1 cells in mice with simultaneous hepatic and extra-hepatic autoimmune disorders.

Authors:  Hassan Jamaleddine; Pere Santamaria; Anmar Khadra
Journal:  Immunology       Date:  2020-09-11       Impact factor: 7.397

3.  The dual role of autoimmune regulator in maintaining normal expression level of tissue-restricted autoantigen in the thymus: A modeling investigation.

Authors:  Tina M Mitre; Massimo Pietropaolo; Anmar Khadra
Journal:  Math Biosci       Date:  2016-10-17       Impact factor: 2.144

Review 4.  Autoimmune responses in T1DM: quantitative methods to understand onset, progression, and prevention of disease.

Authors:  Majid Jaberi-Douraki; Shang Wan Shalon Liu; Massimo Pietropaolo; Anmar Khadra
Journal:  Pediatr Diabetes       Date:  2014-05       Impact factor: 4.866

5.  Unraveling the contribution of pancreatic beta-cell suicide in autoimmune type 1 diabetes.

Authors:  Majid Jaberi-Douraki; Santiago Schnell; Massimo Pietropaolo; Anmar Khadra
Journal:  J Theor Biol       Date:  2014-05-14       Impact factor: 2.691

6.  Investigating the role of T-cell avidity and killing efficacy in relation to type 1 diabetes prediction.

Authors:  Anmar Khadra; Massimo Pietropaolo; Gerald T Nepom; Arthur Sherman
Journal:  PLoS One       Date:  2011-05-10       Impact factor: 3.240

7.  Evolutionary dynamics of human autoimmune disease genes and malfunctioned immunological genes.

Authors:  Soumita Podder; Tapash Chandra Ghosh
Journal:  BMC Evol Biol       Date:  2012-01-25       Impact factor: 3.260

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.